| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| rp173386-500μg |
500μg |
期货  |
| |
| rp173386-1mg |
1mg |
期货 |
|
| 产品名称 | adrenomedullin, AM 1 受体激动剂;AM 2 受体激动剂;AMY 1 受体激动剂;AMY 2 受体激动剂;AMY 3 受体激动剂;CGRP 受体激动剂;CT 受体激动剂 |
|---|---|
| 别名 | 肾上腺髓质素 |
| 英文别名 | AM | mouse adrenomedullin |
| 规格或纯度 | Moligand™ |
| 作用类型 | 激动剂 |
| 作用机制 | AM 1 受体激动剂;AM 2 受体激动剂;AMY 1 受体激动剂;AMY 2 受体激动剂;AMY 3 受体激动剂;CGRP 受体激动剂;CT 受体激动剂 |
| CAS编号和信息 | rp173386 |
|---|
| 1. Struck J, Hein F, Karasch S, Bergmann A. (2013) Epitope specificity of anti-Adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model.. Intensive Care Med Exp, 1 (1): (22). [PMID:26266791] |
| 2. Geven C, van Lier D, Blet A, Peelen R, Ten Elzen B, Mebazaa A, Kox M, Pickkers P. (2018) Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.. Br J Clin Pharmacol, 84 (9): (2129-2141). [PMID:29856470] |
| 3. Geven C, Pickkers P. (2018) The mechanism of action of the adrenomedullin-binding antibody adrecizumab.. Crit Care, 22 (1): (159). [PMID:29895302] |
首页
400-620-6333
